Advertisement

Topics

Esperion rockets as FDA backs cholesterol drug for regulatory filing

11:58 EDT 20 Mar 2017 | thePharmaLetter

US lipid management firm Esperion Therapeutics leapt as much as 52% in morning trading today, after getting…

Original Article: Esperion rockets as FDA backs cholesterol drug for regulatory filing

NEXT ARTICLE

More From BioPortfolio on "Esperion rockets as FDA backs cholesterol drug for regulatory filing"

Quick Search
Advertisement